| | |||||||
| lung cancer | |||||||
| 新闻 | |||||||
| Sacituzumab Tirumotecan Enhances Efficacy in Pretreated EGFR-Mutant NSCLC Sacituzumab tirumotecan showed a manageable safety profile compared to docetaxel in patients with EGFR-mutant advanced non–small cell lung cancer.
| |||||||
| Independence Health System Expands Use of Innovative Technology to Improve Lung ... For lung cancer patients, early diagnosis is crucial for accelerating treatment discussions. Independence Health System's Butler Memorial Hospital ...
| |||||||
Lurbinectedin/Atezolizumab Maintenance Improves Survival in ES-SCLC Stephen V. Liu, MD, discusses the phase 3 IMforte study of lurbinectedin and atezolizumab in extended-stage small cell lung cancer.
| |||||||
| Coach beats multiple myeloma | Louisville, Ky.Norton Healthcare Program provides comprehensive lung cancer treatment · The latest knee replacement technology in 2025. Norton Cancer Institute. If you or a loved one ...
| |||||||
| 查看更多结果 | 修改此快讯 | |||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment